U-PMCB

Q:PMCB - PHARMACYTE BIOTECH INC - https://www.pharmacytebiotech.com

14:11:35 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PMCB - Q	4.6	0.7545	·	0.775	0.2	0.7556	-0.0141	-1.8	41.6	26	625	0.7382 0.78 0.7359	1.51 0.63	13:41:17	Nov 25	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Up -- UPC Restricted: No
Financial Status: Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 625

More trades...

Time ET	Ex	Price	Change	Volume
13:41:17	Q	0.7738	0.0041	6
13:37:12	Q	0.7619	-0.0078	1
13:36:45	Q	0.7739	0.0042	80
13:32:09	Q	0.7721	0.0024	6
13:31:23	Q	0.7556	-0.0141	100
13:30:41	Q	0.7379	-0.0318	6
13:29:49	Q	0.7733	0.0036	6
13:29:48	Q	0.7379	-0.0318	6
13:29:02	Q	0.7727	0.003	6
13:28:35	Q	0.7379	-0.0318	6

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-11-25 09:15	U:PMCB	News Release200	PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
2025-09-02 09:20	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
2025-08-20 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
2025-08-18 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Date ET

Symbol

Type

Headline

2025-11-25 09:15

U:PMCB

News Release

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

2025-09-02 09:20

U:PMCB

News Release

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications